These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1808157)

  • 21. [Contrast media and percutaneous coronary interventions].
    Aubry P; Halna du Fretay X; Tchetche D
    Ann Cardiol Angeiol (Paris); 2007 Jan; 56(1):2-9. PubMed ID: 17343032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Iodinated contrast media and nephropathy. Estimated creatinine clearance for better assessment of renal function and dosage].
    Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
    Ugeskr Laeger; 2004 Jun; 166(26-31):2566-72. PubMed ID: 15285166
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of intravascular low-osmolality contrast agents.
    Swanson DP; Thrall JH; Shetty PC
    Clin Pharm; 1986 Nov; 5(11):877-91. PubMed ID: 3780159
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous contrast medium-induced nephrotoxicity: is the medical risk really as great as we have come to believe?
    Katzberg RW; Newhouse JH
    Radiology; 2010 Jul; 256(1):21-8. PubMed ID: 20574082
    [No Abstract]   [Full Text] [Related]  

  • 25. [Iodinated contrast media and nephropathy--new recommendations. Estimated creatine clearance for better assessment of renal function and dosage].
    Nyman U; Hietala SO; Hellström M; Aspelin P; Björkdahl P; Albrechtsson U; Magnusson A; Måre K; Törnquist C; Ringertz H; Sterner G; Westberg G; Berne C
    Lakartidningen; 2003 Mar; 100(10):840-3, 846-8. PubMed ID: 12680021
    [No Abstract]   [Full Text] [Related]  

  • 26. Pathogenesis of contrast-induced nephropathy: experimental and clinical observations with an emphasis on the role of osmolality.
    Rudnick MR; Goldfarb S
    Rev Cardiovasc Med; 2003; 4 Suppl 5():S28-33. PubMed ID: 14668707
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative safety of high-osmolality and low-osmolality radiographic contrast agents.
    Lasser EC
    Invest Radiol; 1992 May; 27(5):397-9. PubMed ID: 1582825
    [No Abstract]   [Full Text] [Related]  

  • 28. [Nephrotoxicity of iodinated contrast products].
    Christin F; Pottecher T
    Ann Fr Anesth Reanim; 2000 Aug; 19(7):fi128-30. PubMed ID: 10976363
    [No Abstract]   [Full Text] [Related]  

  • 29. [Contrast-induced nephropathy after computer tomography. Hydration and adapted contrast media dosage for the best prophylaxis].
    Haglund M; Hesselstrand R; Nyman U; Sterner G
    Lakartidningen; 2005 Oct 3-9; 102(40):2864-6, 2869-70. PubMed ID: 16255363
    [No Abstract]   [Full Text] [Related]  

  • 30. [Selection of contrast media: current status of understanding].
    Briguori C
    G Ital Cardiol (Rome); 2009 Feb; 10(2):79-87. PubMed ID: 19348144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Osmolality of contrast media--a risk factor in radiological endovascular procedures in children].
    Mikhel'son BA; Guliev ND; Lazarev VV; Poliaev IuA; Vodolazov IuA
    Khirurgiia (Mosk); 1991 Aug; (8):85-9. PubMed ID: 1942890
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The risks of death and of severe nonfatal reactions with high- vs low-osmolality contrast media: a meta-analysis.
    Caro JJ; Trindade E; McGregor M
    AJR Am J Roentgenol; 1991 Apr; 156(4):825-32. PubMed ID: 1825900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. For patients with renal insufficiency, do low-osmolar iodinated contrast agents lessen the risk of nephrotoxicity, compared with high-osmolar agents?
    Hopper KD
    AJR Am J Roentgenol; 1997 Jun; 168(6):1615. PubMed ID: 9168738
    [No Abstract]   [Full Text] [Related]  

  • 34. Contrast-induced nephropathy.
    Kabalan SN; El-Imad BG; Geara AS
    J Med Liban; 2007; 55(1):29-38. PubMed ID: 17489305
    [No Abstract]   [Full Text] [Related]  

  • 35. High-osmolality and low-osmolality contrast agents.
    Paulin S
    N Engl J Med; 1992 Jul; 327(3):202-3; author reply 204-5. PubMed ID: 1608418
    [No Abstract]   [Full Text] [Related]  

  • 36. Comparative safety of high-osmolality and low-osmolality radiographic contrast agents. Report of a multidisciplinary working group.
    Lawrence V; Matthai W; Hartmaier S
    Invest Radiol; 1992 Jan; 27(1):2-28. PubMed ID: 1733876
    [No Abstract]   [Full Text] [Related]  

  • 37. Haemodynamic effects of water-soluble contrast media on the isolated perfused rat kidney.
    el Sayed AA; Haylor JL; el Nahas AM; Salzano S; Morcos SK
    Br J Radiol; 1991 May; 64(761):435-9. PubMed ID: 2036568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contrast media: are there differences in nephrotoxicity among contrast media?
    Solomon R
    Biomed Res Int; 2014; 2014():934947. PubMed ID: 24587997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Liquid gold: low-osmolality contrast media.
    White RI; Halden WJ
    Radiology; 1986 May; 159(2):559-60. PubMed ID: 3515427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Universal versus selective use of low-osmolality contrast media in the 1990s: a radiologist's perspective.
    Silverman PM
    Radiology; 1997 May; 203(2):311-2; discussion 312-4. PubMed ID: 9114080
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.